BIO-key International Receives Nasdaq Extension to Regain $1 Minimum Bid Compliance

Reuters11-08
BIO-key International Receives Nasdaq Extension to Regain $1 Minimum Bid Compliance

BIO-key International Inc. has announced that it received a letter from Nasdaq stating the company has not regained compliance with the minimum bid price requirement of $1.00 per share, as outlined in Nasdaq Listing Rule 5550(a)(2). Despite this, Nasdaq has granted BIO-key an additional 180-day period, until May 4, 2026, to meet the bid price rule. If the company's common stock closes at or above $1.00 per share for at least 10 consecutive business days during this period, it will regain compliance. If not, BIO-key faces potential delisting, though it would have the opportunity to appeal the decision. The company intends to monitor its stock price and may implement a reverse stock split if necessary to maintain its Nasdaq listing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-033877), on November 07, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment